Lupus Trials News
April 24, 2019 The pharmaceutical company Exagen, Inc. announced study results showing that a component of their AVISE SLE Monitor...Read More
April 18, 2019 A large international study has probed the causes of lupus-related psychosis—a serious condition marked by delusions and...Read More
April 11, 2019 The Lupus Research Alliance is pleased to share the results from four clinical trials presented at LUPUS...Read More
April 11, 2019 The bacteria that cause urinary tract infections may trigger lupus flares, a former Alzheimer’s disease therapy has...Read More
New results partially funded by the Lupus Research Alliance found that people with systemic lupus erythematosus have almost double the...Read More
March 28, 2019 A new study published this March in Arthritis & Rheumatology found that deaths among patients with end-stage...Read More
March 19, 2019 A new study published in Lupus showed that mycophenolate mofetil (MMF) is comparable in effectiveness to the...Read More
A new study funded by the Lupus Nephritis Trials Network with support from the Lupus Research Alliance has proposed a...Read More
Lupus Research Alliance and National Minority Quality Forum Release Recommendations to Advance New Lupus Treatments by Increasing Diversity in Clinical Trial Participation
NEW YORK, NY. March 14, 2019. The Lupus Research Alliance (LRA) and the National Minority Quality Forum (NMQF) today released...Read More
March 1, 2019 Proteins of the immune system, known as type I interferons, are responsible in part for manifestations of...
New York, NY– March 1. The Lupus Research Alliance and its affiliate, Lupus Therapeutics announced a collaboration with Takeda Pharmaceutical...Read More
February 28, 2019 NEW YORK, NY. As a co-sponsor of the National Institutes of Health (NIH) public-private Accelerating Medicines Partnership...Read More
February 28, 2019 The biotechnology company Equillium Inc. just announced plans for a Phase 1 study to test the investigational...Read More
February 22, 2019 A study published in the peer-reviewed journal Arthritis & Rheumatology found that people with SLE and particularly...
February 22, 2019 Study results published in the peer-reviewed journal PLOS One showed that elements of physical fitness — muscle...
Bacteria in the Gut May be a Cause of Lupus and Flares: Shows Study Supported by Lupus Research Alliance
NEW YORK, NY. February 19. Pieces of bacteria that escape from the intestines may trigger lupus and associated disease flares...Read More
February 19, 2019 In Healio Rheumatology, Dr. Gregg Silverman, professor of medicine and pathology at NYU School of Medicine, provided...Read More
February 6, 2019 Scientists partly funded by the Lupus Research Alliance have found a potential new way to protect the...Read More
February 1, 2019 Raised levels of a protein osteopontin were shown to indicate lupus nephritis and higher disease activity, in...Read More
February 1, 2019 Today, Lupus Therapeutics, an affiliate of Lupus Research Alliance, is launching our Patient Advocates for Lupus Studies...Read More
Lupus Research Alliance and Lupus Therapeutics Partner on New Phase 3 Trial Testing Potential Benefit of Ustekinumab (Stelara®) in Lupus
February 1, 2019 The Lupus Research Alliance announced that its affiliate Lupus Therapeutics is working with the pharmaceutical company, Janssen,...Read More
A study just published in Annals of Internal Medicine showed that kidney transplantation reduced deaths due to lupus nephritis— kidney inflammation caused by lupus....
An observational study published in Lupus of people with lupus found that of six factors, stress, depression and pain contributed most to...
A small randomized Phase 1 study published in Arthritis & Rheumatology found that the existing asthma treatment omalizumab (Xolair) may improve lupus...
Lupus Research Alliance Announces Translational Research Grants to Speed Development of New Treatments
NEW YORK, NY – January 10. Can “borrowed” drugs for treating other diseases protect the skin in patients with lupus?...Read More
Source: Idorsia LTD Press Release Idorsia Ltd (SIX: IDIA) announced that the first patient has been enrolled into a multiple-dose study...
January 4, 2019 A study just published in Clinical and Experimental Rheumatology found that exposure to periodontal bacteria on the...Read More
A study just published in Clinical and Experimental Rheumatologyfound that exposure to periodontal bacteria on the gums around the teeth can...